Skip to content

Stereotaxis STXS Accrued Compensation

Accrued Compensation at other companies

Medtronic logo
MedtronicMDT
$2.68B+6.5%

Other financials

Income statement

See full
Revenue$6.3M-15.8%
Gross profit$3.8M-6.6%
Operating income-$6.0M-0.9%
Net income-$5.9M-0.7%
EPS (diluted)-$0.06+14.3%

Balance sheet

See full
Cash & equivalents$14.6M+36.7%
Total debt$5.3M-10.0%
Total equity$14.4M+399%
Total assets$54.0M+18.2%

Cash flow

See full
Operating cash flow-$3.4M-93.5%
CapEx$79.0K
Free cash flow-$3.5M

Valuation

See full
Market cap$168.11M-11.6%
Enterprise value$158.77M-15.9%
P/S5.4×-0.6×

Profitability

See full
Gross margin53.9%+0.5pp
Operating margin-71%-14.0pp
Net margin-69.5%-13.7pp
FCF margin-35.5%-2.4pp

Returns & leverage

See full
Return on equity-251.5%-29.9pp
Debt / equity0.4×-1.7×
Current ratio1.6×+0.5×

Where this comes from

Reported directly by Stereotaxis in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent.

The official record: Stereotaxis’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stereotaxis's accrued compensation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stereotaxis's accrued compensation?
Stereotaxis (STXS) reported accrued compensation of $1.24M in Q1 2026.
How has Stereotaxis's accrued compensation changed year-over-year?
Stereotaxis's accrued compensation decreased by 15.5% year-over-year, from $1.47M to $1.24M.
What is the long-term trend for Stereotaxis's accrued compensation?
Over 5 years (2020 to 2025), Stereotaxis's accrued compensation has grown at a -1.9% compound annual growth rate (CAGR), from $2.04M to $1.86M.
What does accrued compensation mean?
Employee wages, salaries, bonuses, commissions, and benefits earned but not yet paid as of the reporting date.